Thus, high expression levels of SLC7A11 and GPX4 are associated with platinum resistance in EOC patients and may be significant independent prognostic factors and potential therapeutic targets in EOC patients with platinum resistance [ 33 ].
1
—
—
Thus, high expression levels of SLC7A11 and GPX4 are associated with platinum resistance in EOC patients and may be significant independent prognostic factors and potential therapeutic targets in EOC patients with platinum resistance [ 33 ].